Nicolas Verbrugge Email

radiochemistry engineer . PRECIRIX

Current Roles

Employees:
52
Revenue:
$8.1M
About
PRECIRIX® is a clinical-stage biotechnology company dedicated to improving the lives of cancer patients by developing novel targeted radiopharmaceuticals using camelid single domain antibody fragments. The company is advancing its lead product CAM-H2 through a Phase I/II clinical trial targeting HER2-positive tumors, while further progressing and broadening its oncology pipeline. PRECIRIX' technology platform allows for a theranostic approach, using the same molecule for patient selection (imaging) and therapy.
PRECIRIX Address
Burgemeester Etienne Demunterlaan 1
Brussels, null
PRECIRIX Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.